Cargando…
Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141722/ https://www.ncbi.nlm.nih.gov/pubmed/34088625 http://dx.doi.org/10.1016/j.acvd.2021.02.005 |
_version_ | 1783696424444100608 |
---|---|
author | Galand, Vincent Hwang, Elliot Gandjbakhch, Estelle Sebag, Frédéric Marijon, Eloi Boveda, Serge Leclercq, Christophe Defaye, Pascal Rosier, Arnaud Martins, Raphaël Pedro |
author_facet | Galand, Vincent Hwang, Elliot Gandjbakhch, Estelle Sebag, Frédéric Marijon, Eloi Boveda, Serge Leclercq, Christophe Defaye, Pascal Rosier, Arnaud Martins, Raphaël Pedro |
author_sort | Galand, Vincent |
collection | PubMed |
description | BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand nine hundred and fifty-four implantable cardioverter defibrillator recipients were followed by remote monitoring during the COVID-19 period (from 01 January to 31 May 2020). Data were obtained from automated remote follow-up of implantable cardioverter defibrillators utilizing the Implicity® platform. For all patients, the type of arrhythmia (atrial fibrillation, ventricular tachycardia or ventricular fibrillation), the number of ventricular arrhythmia episodes and the type of implantable cardioverter defibrillator-delivered therapy were recorded. RESULTS: A total of 472 (7.9%) patients presented 4917 ventricular arrhythmia events. An increase in ventricular arrhythmia incidence was observed after the first COVID-19 case in France, and especially during weeks #10 and #11, at the time of major governmental measures, with an increase in the incidence of antitachycardia pacing delivered therapy. During the 11 weeks before the lockdown order, the curve of the percentage of live-stream television coverage of COVID-19 information matched the ventricular arrhythmia incidence. During the lockdown, the incidence of ventricular arrhythmia decreased significantly compared with baseline (0.05 ± 0.7 vs. 0.09 ± 1.2 episodes per patient per week, respectively; P < 0.001). Importantly, no correlation was observed between ventricular arrhythmia incidence and the curve of COVID-19 incidence. No changes were observed regarding atrial fibrillation/atrial tachycardia episodes over time. CONCLUSIONS: An increase in ventricular arrhythmia incidence was observed in the 2 weeks before the lockdown order, at the time of major governmental measures. Ventricular arrhythmia incidence decreased dramatically during the lockdown. |
format | Online Article Text |
id | pubmed-8141722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81417222021-05-24 Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() Galand, Vincent Hwang, Elliot Gandjbakhch, Estelle Sebag, Frédéric Marijon, Eloi Boveda, Serge Leclercq, Christophe Defaye, Pascal Rosier, Arnaud Martins, Raphaël Pedro Arch Cardiovasc Dis Clinical Research BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand nine hundred and fifty-four implantable cardioverter defibrillator recipients were followed by remote monitoring during the COVID-19 period (from 01 January to 31 May 2020). Data were obtained from automated remote follow-up of implantable cardioverter defibrillators utilizing the Implicity® platform. For all patients, the type of arrhythmia (atrial fibrillation, ventricular tachycardia or ventricular fibrillation), the number of ventricular arrhythmia episodes and the type of implantable cardioverter defibrillator-delivered therapy were recorded. RESULTS: A total of 472 (7.9%) patients presented 4917 ventricular arrhythmia events. An increase in ventricular arrhythmia incidence was observed after the first COVID-19 case in France, and especially during weeks #10 and #11, at the time of major governmental measures, with an increase in the incidence of antitachycardia pacing delivered therapy. During the 11 weeks before the lockdown order, the curve of the percentage of live-stream television coverage of COVID-19 information matched the ventricular arrhythmia incidence. During the lockdown, the incidence of ventricular arrhythmia decreased significantly compared with baseline (0.05 ± 0.7 vs. 0.09 ± 1.2 episodes per patient per week, respectively; P < 0.001). Importantly, no correlation was observed between ventricular arrhythmia incidence and the curve of COVID-19 incidence. No changes were observed regarding atrial fibrillation/atrial tachycardia episodes over time. CONCLUSIONS: An increase in ventricular arrhythmia incidence was observed in the 2 weeks before the lockdown order, at the time of major governmental measures. Ventricular arrhythmia incidence decreased dramatically during the lockdown. Elsevier Masson SAS. 2021-05 2021-05-24 /pmc/articles/PMC8141722/ /pubmed/34088625 http://dx.doi.org/10.1016/j.acvd.2021.02.005 Text en © 2021 Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Research Galand, Vincent Hwang, Elliot Gandjbakhch, Estelle Sebag, Frédéric Marijon, Eloi Boveda, Serge Leclercq, Christophe Defaye, Pascal Rosier, Arnaud Martins, Raphaël Pedro Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
title | Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
title_full | Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
title_fullStr | Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
title_full_unstemmed | Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
title_short | Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
title_sort | impact of covid-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141722/ https://www.ncbi.nlm.nih.gov/pubmed/34088625 http://dx.doi.org/10.1016/j.acvd.2021.02.005 |
work_keys_str_mv | AT galandvincent impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT hwangelliot impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT gandjbakhchestelle impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT sebagfrederic impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT marijoneloi impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT bovedaserge impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT leclercqchristophe impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT defayepascal impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT rosierarnaud impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring AT martinsraphaelpedro impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring |